These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 21397769

  • 21. Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C.
    Miller M, Dobs A, Yuan Z, Battisti WP, Borisute H, Palmisano J.
    Curr Med Res Opin; 2004 Jul; 20(7):1087-94. PubMed ID: 15265253
    [Abstract] [Full Text] [Related]

  • 22. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM.
    Am J Cardiol; 2010 Feb 15; 105(4):487-94. PubMed ID: 20152243
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
    Roth EM, McKenney JM, Kelly MT, Setze CM, Carlson DM, Gold A, Stolzenbach JC, Williams LA, Jones PH.
    Am J Cardiovasc Drugs; 2010 Feb 15; 10(3):175-86. PubMed ID: 20524719
    [Abstract] [Full Text] [Related]

  • 24. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 15; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 25. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 15; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 26. [Metabolic effects of hypolipemic drugs on aged type 2 diabetes].
    Palel G, Coman A, Petrovanu R, Ungureanu D.
    Rev Med Chir Soc Med Nat Iasi; 2001 Mar 15; 105(3):518-20. PubMed ID: 12092185
    [Abstract] [Full Text] [Related]

  • 27. [Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].
    Zeman M, Zák A, Vecka M, Romaniv S.
    Cas Lek Cesk; 2003 Aug 15; 142(8):500-4. PubMed ID: 14626567
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J.
    Am J Cardiol; 2005 Feb 15; 95(4):462-8. PubMed ID: 15695129
    [Abstract] [Full Text] [Related]

  • 29. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.
    Aberg JA, Zackin RA, Brobst SW, Evans SR, Alston BL, Henry WK, Glesby MJ, Torriani FJ, Yang Y, Owens SI, Fichtenbaum CJ, ACTG 5087 Study Team.
    AIDS Res Hum Retroviruses; 2005 Sep 15; 21(9):757-67. PubMed ID: 16218799
    [Abstract] [Full Text] [Related]

  • 30. Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.
    Ramachandran S, Saraf S, Shetty C, Capps N, Bailey C.
    Ann Clin Biochem; 2011 Jan 15; 48(Pt 1):75-8. PubMed ID: 21115572
    [Abstract] [Full Text] [Related]

  • 31. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.
    Am J Cardiol; 2008 Feb 15; 101(4):486-9. PubMed ID: 18312763
    [Abstract] [Full Text] [Related]

  • 32. The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus.
    Stulc T, Ceska R, Marinov I, Skrha J.
    Neuro Endocrinol Lett; 2012 Feb 15; 33 Suppl 2():73-7. PubMed ID: 23183514
    [Abstract] [Full Text] [Related]

  • 33. Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Saha SA, Arora RR.
    Curr Opin Lipidol; 2011 Aug 15; 22(4):270-6. PubMed ID: 21519250
    [Abstract] [Full Text] [Related]

  • 34. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 15; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 35. Simvastatin, fenofibrate, and rhabdomyolysis.
    Jacob SS, Jacob S, Williams C, Deeg MA.
    Diabetes Care; 2005 May 15; 28(5):1258. PubMed ID: 15855605
    [No Abstract] [Full Text] [Related]

  • 36. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S.
    Metabolism; 2005 May 15; 54(5):677-81. PubMed ID: 15877299
    [Abstract] [Full Text] [Related]

  • 37. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E, Rosuvastatin Study Group.
    Am Heart J; 2002 Dec 22; 144(6):1036-43. PubMed ID: 12486428
    [Abstract] [Full Text] [Related]

  • 39. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Dec 22; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 40. Safety considerations with fenofibrate/simvastatin combination.
    Filippatos TD, Elisaf MS.
    Expert Opin Drug Saf; 2015 Dec 22; 14(9):1481-93. PubMed ID: 26134595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.